Our paper on BigPharma AI productivity is featured in Forbes

The research paper "The upside of being a digital pharmer player" by Alexander Schuhmacher, Alexander Gatto, Markus Hinder, Michael Kuss and Oliver Gassmann (ITEM, Chair for Innovation Management) published in Drug Discovery Today has been featured in Forbes.

The world's hope in vaccines for COVID-19 demonstrates; The pharma busniess is one of the few industries where to get the product from the idea to market the company needs to spend about a decade, several billion dollars, and there is about a 90% chance of failure. It becomes interestig when Pharma meets IT "where only the paraniod survive" (Alex Zhavoronkov). 


You can find the full article here.